At a glance
ClinicalIndex Comparison RecordN/ACompleted· 158 enrolled
Drug / intervention
Cortrium C3 device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements
In Brief
A clinical study evaluating Cortrium C3 device and Holter device for Atrial Fibrillation. Completed, enrolled 158 participants across 2 sites.
Detailed Summary
The purpose of this study is to validate the quality of the ECG-signal acquired with the Cortrium C3 monitor. The intention is to evaluate whether the diagnosis of atrial fibrillation based on the ECG signal from the C3 monitor concurs with the current monitoring methods used in clinical practice.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesDenmark
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedMar 2016
Primary CompletionJul 2017
TodayJul 2026
First PostedMar 22, 2016
Enrollment StartFeb 1, 2016
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.3 years ago
Interventions
Cortrium C3 devicedevice
Data is read from Cortrium C3 monitor
Holter devicedevice
Date is read from Holter device